Contract research and contract manufacturing organizations help pharmaceuticals and companies develop their operations through drug discovery to product manufacturing advanced operating models that leverage technology and analytics to enable smart business processes. Strategic Outsourcing has become an industry norm and offers a wide range of services from screening and lead identification to toxicology, pre-clinical studies, clinical trials, manufacturing and marketing. Globally, big pharmaceutical companies are establishing long term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals, leveraging the expertise, GMP approved facilities, advanced technologies, and trained staff available with the CROs and CMOs.
The global business process outsourcing in healthcare market report estimates the market size (Revenue USD million – 2014 to 2021) and composition of this market based on service type (pharmaceutical contract research and manufacturing operations such as drug discovery, clinical trials management, regulatory filing services, API and FDF manufacturing, to sales and marketing of final products), and forecasts growth trends (CAGR% – 2017 to 2021).
The global business process outsourcing in healthcare market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global business process outsourcing in healthcare market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global business process outsourcing in healthcare market and included in this report are Catalent Pharma Solutions, Inc., PRA International Inc., Covance Inc., Cognizant Technology Solutions, Quintiles Transnational Corporation, Parexel International Corporation, DSM, Charles River Laboratories, Piramal Healthcare and Boehringer Ingelheim GmbH.